Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02737332

Public ClinicalTrials.gov record NCT02737332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Active-Controlled, Multi-Center Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer: The STAAR STUDY

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the serum testosterone levels in patients with Metastatic Castration-Resistant Prostate Cancer on SoluMatrix™ Abiraterone Acetate as Compared to Abiraterone Acetate

Study identification

NCT ID
NCT02737332
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
53 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2016 (Actual)
Primary completion
Feb 27, 2017 (Actual)
Completion
Feb 27, 2017 (Actual)
Last update posted
Nov 22, 2021

2016 – 2017

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Alliance Research Laguna Hills California 92653 —
Tower Urology Los Angeles California 90048 —
San Bernardino Urological San Bernardino California 92404 —
Skyline Urology Torrance California 90505 —
Innovative Clinical Research Institute Whittier California 90603 —
Urology Associates, P.C. Englewood Colorado 80113 —
Manatee Medical Research Bradenton Florida 34205 —
North Idaho Urology Coeur d'Alene Idaho 83814 —
The Iowa Clinic West Des Moines Iowa 50266 —
Wichita Urology Group Wichita Kansas 67226 —
Chesapeake Urology Research Associates Towson Maryland 21204 —
Lincoln Urology, PC Lincoln Nebraska 68516 —
Urology Cancer Center Omaha Nebraska 68130 —
Brooklyn Urology Research Group Brooklyn New York 11215 —
Associated Urologist of North Carolina Raleigh North Carolina 27612 —
Urology Clinics of North Texas Dallas Texas 75231 —
Urology of Virginia Virginia Beach Virginia 23462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02737332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02737332 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →